Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2025 Dec 3;167(4):756–766. doi: 10.1097/j.pain.0000000000003880

Systematic review and meta-analyses of nonpharmacological interventions for co-occurring chronic pain and posttraumatic stress disorder

Meaghan L O'Donnell a,b,*, Hussain-Abdulah Arjmand a,b, Mark A Lumley c, Karen Seal d,e, Ramakrishnan Mani f, Michele Sterling g,h, David E Reed II i, Alyssa Sbisa a,b, Matthew J Bair j,k, Sharon Bown a,b, Gabrielle Dupuis l, David Forbes m, Polliann Maher l, Alexander C McFarlane n, G Lorimer Moseley o, John Otis p, David Pedlar q, J Don Richardson r,s, Julia Fredrickson a,b, Larah Maunder t, Daisy Dick u, Erica Wilkinson o, Leone Bennett g, Jacob Blank c, Tracey Varker a,b
PMCID: PMC12994520  PMID: 41380098

Supplemental Digital Content is Available in the Text.

Keywords: Chronic pain, Posttraumatic stress disorder, PTSD, Treatment, Intervention, Meta-analysis

Abstract

Chronic pain and posttraumatic stress disorder (PTSD) frequently co-occur; however, evidence for effective nonpharmacological treatments is limited, resulting in a guidance gap for clinicians. The aim of this systematic review with meta-analysis was to synthesize and analyze the evidence base for nonpharmacological interventions for chronic pain and posttraumatic stress symptoms. MEDLINE, Embase, PsycINFO, and the PTSD Repository were searched for randomized controlled trials of noninvasive, nonpharmacological interventions in adults with chronic pain, PTSD, or both published from January 1, 1988 to August 31, 2024. Studies reporting assessments of both pain intensity and PTSD symptoms were included, and the primary outcomes were change in pain intensity and PTSD symptom severity. Meta-analyses calculated standardized mean differences (SMDs) in change scores for PTSD symptom severity and pain intensity from pre- to posttreatment. Confidence in the evidence was assessed using Grading of Recommendations, Assessment, Development and Evaluation (GRADE). The study is registered with PROSPERO, CRD42024507881. We identified 30 eligible trials (N = 3245 participants). We found evidence (low quality) that trauma-focused treatments may improve both PTSD symptom severity (a medium effect; SMD −0·75, 95% CI −1·37 to −0·12) and pain intensity (a small effect; SMD −0·34, 95% CI −0·56 to −0·11). We found no significant effects for cognitive–behavioral therapies, mind–body therapies, or peripheral modulation interventions for either outcome. Most studies were methodologically weak. Our findings suggest that treatments targeting chronic pain and PTSD should, at minimum, include a trauma-focused therapy component. However, further research is required to develop effective treatments for co-occurring chronic pain and PTSD.

1. Introduction

Chronic pain and posttraumatic stress disorder (PTSD) are often co-occurring. In populations with chronic pain, the prevalence of PTSD ranges from 10% to 20%.59 This co-occurrence is even greater in trauma-exposed populations. For example, chronic pain diagnoses range from 66% to 80%5,9,58 in military veteran samples with PTSD. When the 2 disorders are co-occurring, patients are more likely to screen positive for other psychiatric disorders and medical conditions, to report lower psychosocial and physical functioning, and are more likely to have attempted suicide, compared to those with either chronic pain or PTSD alone.50,51 This added complexity underscores the need to identify the most effective treatments for those with co-occurring chronic pain and PTSD to guide clinicians in their provision of care to these populations.

Several explanatory models have been posited to explain co-occurring chronic pain and PTSD. These models focus on shared biological and psychological vulnerabilities,6 or shared and maintaining psychological processes (e.g., Mutual Maintenance Model57 or Perpetual Avoidance Model).34 More recently, Anderson and Ravn,3 and Reed et al.53 described comprehensive models, the “Conceptual Model of Co-development and Mutual Maintenance of Chronic Pain and PTSD,”36 and the “Integrated Model of Co-occurring Chronic Pain and PTSD.” These recent models acknowledge that shared biological and psychological vulnerability factors—such as anxiety sensitivity, avoidance and hypervigilance, impaired executive function, and cognitive biases—increase the risk of development of both disorders. Both models note that both disorders then mutually maintain each other through psychosocial processes including attentional biases, cognitive and behavioral avoidance, and extensive cognitive demands, which limit coping capacities. These models have the potential to inform treatments for co-occurring chronic pain and PTSD.

Clinical guidelines for the management of chronic pain conditions recommend nonpharmacological multimodal approaches as first-line care, including pain education, behavioral therapies (eg, cognitive behavioral therapy, mindfulness), exercise (eg, physical therapy, yoga), manual therapies (eg, acupuncture, spinal manipulation), and self-management skills.38,43 The only treatments to receive a strong recommendation in PTSD treatment guidelines are trauma-focused psychological therapies.47 Trauma-focused therapies are those that directly target the memory, emotions, and cognitions related to the traumatic event and include the use of fear extinction processes to modify the trauma memory. Clinical guidelines for both chronic pain and PTSD recommend nonpharmacological interventions as first-line treatments, which suggests that interventions designed to target co-occurring chronic pain and PTSD should also primarily have a nonpharmacological focus.

There have been several attempts to summarise the nonpharmacological treatment of co-occurring chronic pain with PTSD, but all have focused specifically on psychological therapies. Although several narrative reviews exist,35,52 there has been only 1 systematic review and meta-analysis on the topic.26 Goldstein et al.26 conducted a meta-analysis of 10 randomised controlled trials (RCTs) of psychological interventions that targeted both chronic pain and PTSD. They reported psychological therapies were associated with a medium effect for PTSD symptom severity and a small effect for pain intensity. However, this study has limitations including (1) only focusing on posttreatment outcomes and not change from baseline to posttreatment; (2) grouping all psychological therapies together regardless of mechanisms of action; and (3) the review search was conducted 8 years ago.

We established an International Co-occurring Chronic Pain and PTSD Collaboration, which consisted of 19 internationally recognised research experts in chronic pain and/or PTSD and 3 lived experience experts. Members were from the United States, Canada, New Zealand, and Australia. The collaboration agreed that people who experience co-occurring chronic pain and PTSD are at heighted clinical risk, and clinicians are often met with treatment challenges and nonresponse. The collaboration identified that it was timely to increase our understanding of the evidence. Thus, the aim of this systematic review and meta-analysis was to review all randomised controlled trials of nonpharmacological interventions for chronic pain and PTSD.

2. Methods

2.1. Identification and selection of studies

To identify interventions that were aimed at either PTSD or chronic pain, but potentially effective for both, we included trials that targeted both or 1 condition, so long as outcomes were collected for both. To identify RCTs of treatments targeting PTSD, we accessed the National Center for PTSD Clinical Trials Database: PTSD-Repository.44 This comprehensive repository includes information on all peer-reviewed English-language published RCTs of PTSD treatments for adults with PTSD. Studies published from January 1988 to April 2024 are currently included in the PTSD repository. We included all studies that included a measurement of pain intensity. To identify RCTs of treatments targeting chronic pain, we searched Medline, Embase, and PsycInfo to identify English-language RCTs published between 1988 and February 2024 (with an update conducted in August 2024). The databases were searched using combinations of key words related to pain, study design, and intervention. Once RCTs were identified, studies were included if they measured posttraumatic stress symptoms. See Supplementary Table 1, http://links.lww.com/PAIN/C429 for an example search strategy. The review was prospectively registered with PROSPERO in March 2024 (registration ID CRD42024507881).

2.2. Study eligibility and screening procedures

Trials were included if they met the following criteria: peer reviewed RCT; assessed effects of noninvasive standalone or multimodal nonpharmacological interventions; English language; adults ≥18 years; sample included at least 80% of participants diagnosed with PTSD OR chronic pain OR co-occurring pain and PTSD. We required that studies included a validated assessment of both PTSD symptom severity and pain intensity/severity, which were assessed at both baseline and posttreatment (throughout this manuscript, the term pain intensity has been used when referring to either pain intensity or severity). Studies with assessments of pain interference or pain-related disability but not pain intensity were excluded. We chose to focus on pain intensity because it remains one of the most widely used metrics of the pain experience, and pain reduction remains a top priority for patients when seen in clinical settings. Records were screened on title and abstract, followed by full-text assessment. Both stages were performed in Covidence independently by 2 team members, with discrepancies resolved through discussion with a third team member.

2.3. Data extraction and management

The key variables of interest were treatment-level means and standard deviations for scores on assessments of PTSD symptom severity and pain intensity at baseline and posttreatment. Data were extracted on sample characteristics including age, sex, population (eg, community, military/veteran), country, social determinants (eg, marital status, employment, education), intervention, and control condition(s) (eg, treatment type, duration, interventionist). Study methodology variables including study year and how both PTSD symptom severity and pain intensity were assessed at baseline and posttreatment. For RCTs identified via the PTSD repository, only means and standard deviations were available from the repository, all other variables were extracted by the research team. Corresponding authors of included RCTs were contacted for missing data where necessary. One research team member extracted data and a second independently checked all data for accuracy and completeness. Any discrepancies were resolved through discussion with a third team member. Extracted data were managed using Research Electronic Data Capture (REDCap) tools hosted at The University of Melbourne.28 Research electronic data capture is a secure and flexible web-based software platform designed to support data capture for research studies. A custom data extraction template was designed in REDCap into which authors entered and collated extracted data.

2.4. Risk of bias rating

Risk of bias ratings for 10 studies were sourced from the PTSD-Repository, which used the Cochrane risk-of-bias tool version 2 for randomized trials (ROB 2)62 to assign studies ratings of low risk, some concern, or high risk. This rating was based on assessment of 5 domains: the randomization process, deviations from intended interventions, missing outcome data, measurement of outcomes, and selection of the reported result.62 The remaining 20 studies, for which PTSD Repository risk of bias ratings were not available, were independently rated using the ROB 2 by 2 team members.

2.5. Statistical methods

Included studies were analyzed across 4 treatment categories identified through discussion and consensus with the International Co-occurring Chronic Pain and PTSD Collaboration (ie, the author group). These included (1) trauma-focused interventions; (2) cognitive–behavioral therapies (CBT) that were not trauma-focused; (3) mind–body interventions; and (4) peripheral modulation interventions (see Table 1 for treatment definitions). Additional subgroup analyses were also conducted to determine whether the type of control condition within studies influenced results. Two control conditions were classified. A control condition was deemed to be “minimal contact” if it involved no intervention or only limited engagement. This group consisted of waitlists, which typically involved assessments only, and sometimes included additional nontherapeutic components, such as a multivitamin, minimal support, or occasional check-ins. A control condition was deemed “active” if it was designed to offer a limited treatment component or a placebo, such as supervised/guided exercise, problem solving skills, and stress management. Where the comparison condition was an alternative intervention that was designed to offer full therapeutic benefit, it was put into an “alternate intervention” category.

Table 1.

Intervention categories, descriptions, and specific studies.

Intervention Description of intervention Studies
(1) Trauma-focussed interventions (n = 7) Interventions that directly targeted trauma memories by using a trauma memory exposure paradigm. These included Trauma-Focused CBT, Group CBT for PTSD, Emotional Freedom Technique, Narrative Exposure Therapy, biofeedback supported CBT (with exposure), and Eye Movement Desensitization and Reprocessing Andersen et al.4; Beck et al.8; Dunne et al.17; Geronilla et al.24; Neuner et al.39; Wang et al.66; Zat Ciftci et al.70
(2) Cognitive–behavioral therapies (n = 7) Interventions that focus on modifying maladaptive thoughts and behavior patterns without direct focus on exposure to the trauma memory. These included CBT, Cognitive restructuring, Acceptance and Commitment Therapy, Internet-delivered CBT, CBT for interstitial cystitis/bladder pain syndrome, CBT plus Acceptance and Commitment Therapy Buhmann et al.11; Carlsson et al.13; Dindo et al.15; Gasslander et al.23; McKernan et al.37; Wicksell et al.67; Yarns et al.69
(3) Mind–body interventions (n = 9) Interventions that promoted sensory awareness, mental relaxation, and control of cognitions. These included Somatic Experiencing, Holistic yoga, Mindfulness-Oriented Recovery Enhancement, Yoga and mantra repetition, Mindfulness-Based Stress Reduction, Basic body awareness, and Mindfulness meditation Andersen et al.2; Andersen et al.1; Davis et al.14; Garland et al.22; Groessl et al.27; Kearney et al.31; Nordbrandt et al.42; Roseen et al.55; Williams et al.68
(4) Peripherally applied modulation interventions (n = 3) Interventions that engaged or manipulated peripheral body systems, targeting sensory pathways or trigger points. These included acupuncture, Tennant Biomodulator, and dry needling plus exercise Engel et al.18; Peacock et al.45; Sterling et al.61

CBT, cognitive–behavior therapy; PTSD, posttraumatic stress disorder.

All statistical analyses were performed using program R.48 Meta-analyses were conducted using the “meta” package64 to examine the individual and overall effects of treatment interventions on self-reported PTSD symptom severity and pain intensity. Separate meta-analyses were conducted for each treatment category when more than 1 study was available for analysis (Table 1). When there were different control groups used across studies of a given treatment category (ie, “minimal contact” or “active” groups), subgroup analyses were performed to determine differential effects. Pooled effect sizes, expressed as standardized mean differences, and corresponding confidence intervals were calculated using fixed- or random-effects models. The choice of model was guided by assessment of heterogeneity: random-effects models were used when heterogeneity was elevated (I2 > 30%).29,30 Effect sizes were interpreted using conventional thresholds: standardized mean differences of 0.2, 0.5, and 0.8 were considered small, medium, and large, respectively. To assess the effect of treatments, standardized mean differences were specifically calculated using change scores (posttreatment minus baseline) rather than only posttreatment scores. Symptom change across time provides a more robust assessment of treatment effect by accounting for any baseline differences between conditions that can occur even with randomization. For intervention and control groups, separate change scores for PTSD symptom severity and pain intensity were derived using mean baseline and posttreatment data.

The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

3. Results

3.1. Study characteristics

The review identified 30 RCTs that met inclusion criteria; see Figure 1 for the PRISMA flow diagram summarizing the study selection and retention process. Across these studies, 12 of the interventions targeted PTSD (and assessed pain intensity), 11 targeted pain (and assessed PTSD symptom intensity), and 7 targeted co-occurring PTSD and pain. A total of 25 studies were included in meta-analyses, with 18 of these studies published since the search was conducted for the Goldstein (2019) review. The 25 studies were distributed across 4 separate meta-analyses (2 included subgroup analyses). The remaining 5 studies were not included in any meta-analyses; 4 were not included because each represented a unique treatment category without additional studies for pooling (ie, repetitive Transcranial Magnetic Stimulation [rTMS], Collaborative Care, Pain Neuroscience Education, and Resilient Intrinsic Self-Regulation in Extremities [RISE])10,19,32,63; the fifth study involved a CBT intervention compared with another therapy, but could not be meta-analyzed because of the absence of studies with a similar comparison group.69 However, the standardized mean differences of change scores for these studies were still calculated and reported for transparency and completeness.

Figure 1.

Figure 1.

PRISMA flow diagram illustrating the study selection process from database search to final inclusion and meta-analysis.

Study sample sizes ranged between n = 20 and n = 666. Studies were conducted in the United States (15 studies), Denmark (7), Australia (3), Sweden (2), Canada (1) Kosovo (1), Germany (1), and Türkiye (1) (1 study recruited from 2 countries). Study populations included those with clinical or subclinical levels of PTSD symptoms (n = 19), chronic back pain (n = 6), whiplash associated disorder (n = 3), Gulf War Illness with musculoskeletal pain involving 2 or more regions of the body (n = 1), interstitial cystitis/bladder pain syndrome (n = 1), persistent posttraumatic headache (n = 1), and fibromyalgia (n = 1); some studies included participants with more than 1 diagnosis. Study characteristics are reported in Supplementary Table 2, http://links.lww.com/PAIN/C429.

3.2. Risk of bias

The complete summary of risk of bias for each study is presented in Supplementary Materials Table 3, http://links.lww.com/PAIN/C429. Most studies were rated with high (n = 11, 37%) or some risk of bias (n = 11, 37%) with fewer studies receiving a low risk of bias rating (n = 8, 26%). Bias usually resulted from insufficient detail regarding randomization and allocation procedures (n = 14, 46%), as well as lack of detail surrounding treatment adherence (n = 15, 50%). There was often bias in measurement of outcomes across studies because of a combination of the sole use of self-report outcome assessments and challenges with blinding because of nature of interventions and trial designs (n = 17, 57%). There was also a moderate amount of bias because of how missing data were handled (eg, per-protocol rather than intent-to-treat analyses, n = 9, 30%). Finally, some studies (n = 6, 20%) did not report publishing a protocol or registering their study in a clinical trial registry, which is recommended practice33 and potentially compromises transparency and confidence in the results.

3.3. Effect of interventions on posttraumatic stress disorder symptom severity and pain intensity

The effects of interventions on PTSD symptom severity and pain intensity are presented in Figures 2–4. Figure 2 presents the effect of trauma-focused therapies on outcomes, with subgroup analyses when the intervention is compared to either minimal contact or active control groups. Figure 3 presents the effects of cognitive–behavioral therapies on outcomes, with subgroup effects. Finally, Figure 4 presents the effects of mind–body interventions and peripheral modulation interventions on PTSD and pain outcomes when compared against an active control group (ie, there were not any minimal contact studies). All other comparisons are discussed in the text.

Figure 2.

Figure 2.

Forest plot of PTSD symptom severity and pain intensity change scores for trauma-focused therapies: overall analysis, and subgroup analysis by control type (ie, minimal contact or active control). PTSD, posttraumatic stress disorder. Note: Bottom rows represent results of overall analysis including all studies regardless of control type. CI=confidence interval; PTSD=posttraumatic stress disorder; SMD=standardized mean difference (negative SMD values indicate greater symptom reduction in the intervention group compared to the minimal contact/active control group).

Figure 4.

Figure 4.

Forest plot of PTSD severity and pain intensity change scores for mind–body interventions and peripheral modulation: overall analysis, and subgroup analysis by control type (ie, only active control). PTSD, posttraumatic stress disorder. Note: CI=confidence interval; PTSD=posttraumatic stress disorder; SMD=standardized mean difference (negative SMD values indicate greater symptom reduction in the intervention group compared to the active control group).]

Figure 3.

Figure 3.

Forest plot of PTSD symptom severity and pain intensity change scores for cognitive–behavioral therapies: overall analysis, and subgroup analysis by control type (ie, minimal contact or active control). PTSD, posttraumatic stress disorder. Note: Bottom rows represent results of overall analysis including all studies regardless of control type. CI=confidence interval; PTSD=posttraumatic stress disorder; SMD=standardized mean difference (negative SMD values indicate greater symptom reduction in the intervention group compared to the minimal contact/active control group).

Seven RCTs delivered trauma-focused therapies. The overall meta-analysis of the 7 trials revealed significantly greater reductions in PTSD symptom severity with a medium effect (standardized mean difference [SMD] = −0.75, confidence interval [CI] = −1.37, −0.12, P < 0.05), and pain intensity with a small effect (SMD = −0.34, CI = −0.56, −0.11, P < 0.01), for trauma-focused therapies compared to controls. Six RCTs delivered cognitive–behavioral therapies and compared treatment effects against a control group. The overall meta-analysis showed no significant difference in reduction of PTSD symptom severity (SMD = −0.08, CI = −0.27, 0.11, P = 0.42) or pain intensity (SMD = −0.01, CI = −0.16, 0.18, P = 0.92), for cognitive–behavioral therapies compared to controls. Subgroup analyses examining treatment effects of interventions (ie, trauma-focused therapies or cognitive–behavioral therapies) separately by control group type (ie, minimal contact or active control) revealed no significant differences between groups in PTSD or pain outcomes (all P > 0.05).

Nine RCTs delivered mind–body therapies. All RCTs compared mind–body therapies against an active control (n = 9). The meta-analysis revealed no significant difference in symptom reductions between mind–body therapies and active controls for PTSD (SMD = −0.12, CI = −0.30, 0.06, P = 0.20) and pain intensity (SMD = −0.14, CI = −0.41, 0.14, P = 0.33). Three RCTs delivered a peripheral modulation intervention (1 RCT included 2 different peripheral modulation intervention arms). All RCTs compared peripheral modulation interventions to an active control (n = 3). The meta-analysis showed no significant difference in symptom reduction between peripheral modulation and active controls for PTSD symptom severity (SMD = −0.26, CI = −0.93, 0.40, P = 0.44) or pain intensity (SMD = −0.13, CI = −0.53, 0.28, P = 0.53).

One RCT compared a cognitive–behavioral therapy to another therapy (Emotional Awareness and Expression Therapy [EAET]). In this study, there was no significant difference in symptom reduction between groups for PTSD symptom severity (SMD = 0.21, CI = −0.22, 0.64, P = 0.34); however, there was significantly greater reductions in pain intensity in participants in the EAET group than in participants in the cognitive–behavior therapy group, with a large effect (SMD = 0.81, CI = 0.42, 1.19, P < 0.001).

Four RCTs were not included in any meta-analyses because their interventions did not fit the treatment categories.10,19,32,63 Repetitive Transcranial Magnetic Stimulation did not differ from an active controls (Sham rTMS)63 in reducing either PTSD symptom severity (SMD = −0.12, CI = −1.00, 0.76, P = 0.79) or pain intensity (SMD = −0.08, CI = −0.95, 0.80, P = 0.86). Collaborative care (ie, an integrative model combining care manager engagement, stepped psychosocial treatments, electronic symptom monitoring, and centralized specialist support to enhance mental healthcare delivery in a primary care setting) resulted in minimal to small reductions in PTSD symptom severity (SMD = −0.20, CI = −0.35, −0.05, P < 0.05) but not pain intensity (SMD = −0.13, CI = −0.29, 0.02, P = 0.09), against an active control (usual care).19 An intervention labelled RISE (RISE; a 4-module resilience intervention focusing on engagement, social connections, pain management, and life improvement) did not differ for reducing PTSD symptom severity (SMD = −0.15, CI = −0.67, 0.36, P = 0.56) but led to significantly greater pain intensity reduction than minimal contact controls (SMD = −0.53, CI = −1.05, −0.00, P < 0.05).32 The effect size was medium. Pain neuroscience education did not differ in reducing PTSD symptom severity (SMD = −0.31, CI = −1.02, 0.40, P = 0.39) or pain intensity (SMD = −0.24, CI = −0.94, 0.47, P = 0.52) compared to an active control (stress management education intervention).10 Also, 2 interventions from additional treatment arms of existing RCTs were not included in any meta-analysis.42,68 A mixed physical activity intervention did not differ from an active control (a treatment combining medical care with flexible CBT, acceptance and commitment therapy, stress management, and mindfulness) in reducing PTSD symptom severity (SMD = 0.00, CI = −0.27, 0.27, P = 1.00) or pain intensity (SMD = 0.00, CI = −0.26, 0.27, P = 0.98).42 A hypnosis intervention resulted in significantly lower reductions in PTSD symptom severity (small effect: SMD = 0.27, CI = 0.01, 0.54, P < 0.05), but not pain intensity (SMD = −0.14, CI = −0.40, 0.13, P = 0.31) compared to an active control (chronic pain education intervention).68

3.4. Analysis of heterogeneity

Patterns of heterogeneity varied across intervention categories and outcomes. For trauma-focused therapies, substantial heterogeneity was observed (I2 = 85.8%, P < 0.01) with results indicating that although the overall direction of effects favored these therapies, the magnitude of effect sizes varied considerably across studies. In contrast, cognitive–behavioral therapies showed no significant heterogeneity in outcomes related to PTSD or pain intensity, suggesting more consistent effects across studies. Mind–body therapies demonstrated moderate to high heterogeneity for both PTSD symptom severity (I2 = 52.0%, P < 0.05) and pain intensity (I2 = 79.2%, P < 0.001), which was reflective of variability in both the strength and direction of treatment effects. Peripheral modulation interventions exhibited significant heterogeneity for PTSD outcomes (I2 = 79.8%, P < 0.01) but not for pain outcomes. This discrepancy is likely attributable to a single study (Engel et al., 2014), which reported unusually large effects on PTSD symptom severity but minimal effects on pain intensity.

3.5. Quality of evidence outcome assessment

The quality of evidence was assessed across meta-analyses based on GRADE criteria, with ratings downgraded for any serious (1 level) or very serious concerns (2 levels). Overall, the quality of evidence was rated as “low” or “very low” across comparisons, and primarily because of the heterogeneity of outcomes (inconsistency of intervention effects) across studies, limited sample sizes and wide confidence intervals (imprecision). Although there did not appear to be significant issues with indirectness or publication bias, some instances of concern surrounding risk of bias were noted. A comprehensive breakdown of GRADE assessments (including funnel plots assessing publication bias) is presented in the Supplementary Materials, http://links.lww.com/PAIN/C429.

4. Discussion

This study aimed to determine the current evidence base for nonpharmacological treatments for co-occurring chronic pain and PTSD. This systematic review and meta-analysis involved screening over 15,000 papers and conducting full-text reviews of 3000. In addition to including studies targeting both chronic pain and PTSD, we included studies that targeted either chronic pain or PTSD but that also assessed the impact of the intervention on pain intensity and PTSD symptom severity. We found evidence (low quality) that trauma-focused treatments may improve both PTSD symptom severity (a medium effect) and pain intensity (a small effect). We did not find any evidence that cognitive–behavioral, mind–body, or peripheral modulation interventions reduced either PTSD symptom severity or pain intensity.

Our paper replicates and extends the findings from Goldstein et al.26 Our finding that trauma-focused treatments had a medium effect for PTSD symptom severity and small effect for pain intensity is consistent with the overall Goldstein et al.26 finding, which was based on 10 RCTs. In their subgroup analysis of 3 exposure-based studies for PTSD (comparable to our trauma-focused treatments), Goldstein et al.26 found a large effect on PTSD severity and a medium effect on pain reduction. Our systematic review updates the findings from Goldstein et al.26 by including an additional 5 trauma-focused intervention studies in the analysis. Our study extends the Goldstein et al.26 findings by examining treatment response (changes from baseline to posttreatment) rather than simply posttreatment response. As such, we accounted for any random differences between groups that are not addressed by using posttreatment data only. We did not replicate the Goldstein et al.26 findings of an effect of mindfulness on PTSD symptoms (but not pain). This may have been because we had a broader group of mind–body studies, which included mindfulness as well as yoga and somatic interventions.

Theoretical models3,53 of the co-occurrence of PTSD and chronic pain that highlight how the 2 disorders mutually maintain each other would suggest that if 1 component of the mutual maintenance pathway is addressed, it would lead to a cascading decrease in other components. The findings from this review are consistent with this theory. Our meta-analysis found that trauma-focused therapies that target traumatic memories reduce not only PTSD symptoms (medium effect) but also have small but significant effect on reducing pain intensity. Trauma-focused therapies target avoidance behaviors (initially avoidance of intrusive memory phenomena, then avoided thoughts, places, people, and situations). The experiential learning that occurs by “not avoiding” may improve symptoms and lead to generalization so that other avoided behaviors (eg, movement or exercise) decrease. It is reasonable to hypothesize that by targeting a reduction in avoidance behaviors, activity and sense of control increase, disability and pain decrease, thus breaking the fear-avoidance behavior vicious cycle.65 Further mechanistic research is required to see if these hypothesised cascading effects do indeed occur over time.

The trauma-focused treatments for PTSD in this review included Eye Movement Desensitization and Reprocessing, Narrative Exposure Therapy, and Trauma-focused CBT (which is a combination of cognitive therapy and prolonged exposure). Although these therapies were found to be effective in this review, trauma-focused treatments are often underused in clinical practice because of provider's fear of retraumatising patients and other misconceptions.25 This concern is especially prevalent when patients present with complexity including childhood trauma.20 Although evidence does not support these concerns, good education and training is essential to increase the skill and confidence of providers to deliver trauma-focused interventions. This may be of particular importance to providers who primarily focus on treating chronic pain. Assessment of trauma and PTSD and training in the delivery of trauma-focused treatments should be emphasised as an important area of professional development.

Our finding that CBT did not have a significant impact on pain intensity is contrary to some reviews that have found CBT to have some impact on pain intensity.12 It is important to note that the effect of CBT on pain intensity varies as a function of the control condition (with effect sizes ranging from −0.22 to −0.16 against treatment as usual or waitlist), and even smaller or not significant against active controls (−0.09 to −0.08).12 Given our sample of studies included a number with active control, this could account for our lack of significant findings. It is also recognised that our sample of studies represents a subset of all CBT and pain intensity studies and limiting our sample to those who have been impacted by trauma may have also influenced these findings.

The quality of evidence assessments in this review was assessed using GRADE, and generally studies were low in quality. This was because of methodological limitations including inadequate reporting of randomization procedures, poor treatment adherence documentation, small sample sizes, and inconsistent intervention effects. Although these limitations constrain the strength of our conclusions, the patterns of findings identified still warrant serious consideration. More rigorous, well-designed trials are needed to strengthen the evidence base and draw definitive conclusions.

Despite the relatively large number of studies in this review, the lack of findings examining the treatment of co-occurring chronic pain and PTSD reflects a concerning deficit in intervention research. This may be reflective of a potentially siloed approach to PTSD and chronic pain treatment research. Our International Co-occurring Chronic Pain and PTSD Collaboration is an attempt to breakdown these siloes to move the field forward.

This study should be considered alongside its limitations. We targeted pain intensity or severity as the key pain-related outcome rather than pain interference because models of comorbid pain and trauma focus on the experience of pain as both a consequence of trauma and a driver of trauma-related symptoms. However, we recognize that many interventions seek to reduce pain interference and improve functioning rather than reduce pain itself and we cannot comment on the efficacy of these treatments. We included not only studies of comorbid PTSD and chronic pain but also studies that measured PTSD symptoms and pain intensity in people, some of whom may not have met full diagnostic criteria for PTSD or chronic pain. This may have resulted in floor effects where a given intervention may not have impacted symptoms because the symptoms were relatively low in the first place. Both the mind–body and peripherally applied modulation interventions groups included studies that were quite heterogeneous about interventions as well as populations and trauma types. Our lack of significant results in the meta-analysis of these groups of studies may reflect this heterogeneity. Although study-level demographic characteristics were extracted from studies, we did not examine their potential moderating effects on PTSD or pain outcomes as the small number of studies in each subgroup would have limited the reliability of such analyses. We also note that most of the outcome data was retrospective self-report data, especially when measuring pain intensity. Three studies used methods such as electronic diaries or ecological momentary assessment, which are more likely to provide increased accuracy in the measurement of pain intensity, and future studies should consider these methods.56 Finally, it is worth noting that although chronic pain is a distinct entity, subgroups/clusters7,16,46,49,54,60 of chronic pain exist with differing levels of psychological mechanisms and are mediated by different pain mechanisms (ie, nociceptive, neuropathic, and nociplastic). Future research should test whether the beneficial effects of psychological interventions vary according to chronic pain subgroups (eg, high psychological distress subgroup) or pain mechanism type (eg, nociplastic pain)21,41 and chronic primary or secondary pain.40,54

We found evidence that trauma-focused therapies may have a medium magnitude beneficial effect on PTSD symptom severity and a small benefit on pain intensity. Findings from this systematic review and meta-analysis suggest that interventions that aim to treat co-occurring chronic pain and PTSD should consider including a trauma-focused therapy component. However, there is a need to conduct more high quality mechanistic and treatment studies that aim to address this comorbidity. The International Chronic Pain and PTSD Collaboration offers a way for the 2 areas of research to collaborate and move the field forward.

Conflict of interest statement

M.O.D., H.A.A., and T.V. received grant funding from the Chronic Pain Centre of Excellence for Canadian Veterans to establish the International Co-occurring Chronic Pain and PTSD Collaboration, and to conduct of this study. G.L.M. has received support from NHMRC of Australia, MRFF of Australia, Reality Health, ConnectHealth UK, Institutes of Health California, AIA Australia, Workers' Compensation Boards and professional sporting organisations in Australia, the UK, and the US. Professional and scientific bodies have reimbursed him for travel costs related to presentation of research on pain and pain education at scientific conferences/symposia. He has received speaker fees for lectures on pain, pain education, and rehabilitation. He receives royalties for books on pain and pain education from NOIgroup Publications. He is nonpaid CEO of the nonprofit Pain Revolution. All other authors declare no competing interests.

Appendix A. Supplemental digital content

Supplemental digital content associated with this article can be found online at http://links.lww.com/PAIN/C429.

Supplementary Material

SUPPLEMENTARY MATERIAL
jop-167-756-s001.pdf (617.7KB, pdf)

Acknowledgements

The authors acknowledge the financial support of the Chronic Pain Centre of Excellence for Canadian Veterans for establishing the International Co-occurring Chronic Pain and PTSD Collaboration, and the conduct of this study. The funder of the study had no role in the study design, data collection, data interpretation, or writing of the paper.

The authors acknowledge and thank their lived and living experience experts and their families for their input to this work.

Contributors: All authors were involved in the conceptualization of the study and the development of the methodology. Data collection and analysis: M.O.D., H.A.A., T.V. All authors were involved in data interpretation. Writing—original draft: M.O.D., H.A.A., T.V. All authors provided comment and edits on draft. M.O.D., H.A.A., and T.V. accessed and verified the data. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Data sharing: All data used in this paper can be made available for further research on reasonable written request.

Footnotes

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.painjournalonline.com).

Contributor Information

Hussain-Abdulah Arjmand, Email: harjmand@unimelb.edu.au.

Mark A. Lumley, Email: mlumley@wayne.edu.

Karen Seal, Email: karen.seal@va.gov.

Ramakrishnan Mani, Email: ramakrishnan.mani@otago.ac.nz.

Michele Sterling, Email: m.sterling@uq.edu.au.

David E. Reed, II, Email: davider2@uw.edu.

Alyssa Sbisa, Email: alyssa.sbisa@unimelb.edu.au.

Matthew J. Bair, Email: mbair@iupui.edu.

Sharon Bown, Email: sharon@sharonbown.com.au.

Gabrielle Dupuis, Email: gabrielle.dupuis@theroyal.ca.

David Forbes, Email: dforbes@unimelb.edu.au.

Polliann Maher, Email: polliann.maher@theroyal.ca.

Alexander C. McFarlane, Email: alexander.mcfarlane@adelaide.edu.au.

G. Lorimer Moseley, Email: lorimer.moseley@unisa.edu.au.

John Otis, Email: johnotis@bu.edu.

David Pedlar, Email: david.pedlar@queensu.ca.

J. Don Richardson, Email: don.richardson@sjhc.london.on.ca.

Julia Fredrickson, Email: juliafred@gmail.com.

Larah Maunder, Email: larah.maunder@queensu.ca.

Daisy Dick, Email: daisyd1376@gmail.com.

Erica Wilkinson, Email: erica.wilkinson@mymail.unisa.edu.au.

Leone Bennett, Email: leone.bennett@uq.edu.au.

Jacob Blank, Email: jblank@wayne.edu.

Tracey Varker, Email: tvarker@unimelb.edu.au.

References

  • [1].Andersen TE, Ellegaard H, Schiottz-Christensen B, Mejldal A, Manniche C. Somatic experiencing® for patients with low back pain and comorbid posttraumatic stress symptoms—a randomised controlled trial. Eur J Psychotraumatol 2020;11:1797306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Andersen TE, Lahav Y, Ellegaard H, Manniche C. A randomized controlled trial of brief somatic experiencing for chronic low back pain and comorbid post-traumatic stress disorder symptoms. Eur J Psychotraumatol 2017;8:1331108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Andersen TE, Ravn SL. Chronic pain and comorbid posttraumatic stress disorder: potential mechanisms, conceptualizations, and interventions. Curr Opin Psychol 2025;62:101990. [DOI] [PubMed] [Google Scholar]
  • [4].Andersen TE, Ravn SL, Armfield N, Maujean A, Requena SS, Sterling M. Trauma-focused cognitive behavioural therapy and exercise for chronic whiplash with comorbid posttraumatic stress disorder: a randomised controlled trial. PAIN 2021;162:1221–32. [DOI] [PubMed] [Google Scholar]
  • [5].Asmundson AJ, Paluszek MM, Sommer JL, Bolton S-L, Sareen J, Afifi TO, El-Gabalawy R, Asmundson GJ. Longitudinal course of posttraumatic stress disorder and chronic pain conditions: a population-based study of Canadian military personnel over 16 years. J Anxiety Disord 2025;113:103025. [DOI] [PubMed] [Google Scholar]
  • [6].Asmundson GJ, Coons MJ, Taylor S, Katz J. PTSD and the experience of pain: research and clinical implications of shared vulnerability and mutual maintenance models. Can J Psychiatr 2002;47:930–7. [DOI] [PubMed] [Google Scholar]
  • [7].Asquini G, Devecchi V, Viscuso D, Bucci R, Michelotti A, Liew BX, Falla D. An exploratory data-driven approach to classify subgroups of patients with temporomandibular disorders based on pain mechanisms. J Pain 2025;26:104721. [DOI] [PubMed] [Google Scholar]
  • [8].Beck J, Coffey S, Foy D, Keane T, Blanchard E. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther 2009;40:82–92. [DOI] [PubMed] [Google Scholar]
  • [9].Beckham JC, Crawford AL, Feldman ME, Kirby AC, Hertzberg MA, Davidson JRT, Moore SD. Chronic posttraumatic stress disorder and chronic pain in Vietnam combat veterans. J Psychosomat Res 1997;43:379–89. [DOI] [PubMed] [Google Scholar]
  • [10].Benedict TM, Nitz AJ, Gambrel MK, Louw A. Pain neuroscience education improves post-traumatic stress disorder, disability, and pain self-efficacy in veterans and service members with chronic low back pain: preliminary results from a randomized controlled trial with 12-month follow-up. Mil Psychol 2024;36:376–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Buhmann CB, Nordentoft M, Ekstroem M, Carlsson J, Mortensen EL. The effect of flexible cognitive–behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatr 2016;208:252–9. [DOI] [PubMed] [Google Scholar]
  • [12].de C Williams AC, Fisher E, Hearn L, Eccleston C. Evidence-based psychological interventions for adults with chronic pain: precision, control, quality, and equipoise. PAIN 2021;162:2149–53. [DOI] [PubMed] [Google Scholar]
  • [13].Carlsson J, Sonne C, Vindbjerg E, Mortensen EL. Stress management versus cognitive restructuring in trauma-affected refugees—a pragmatic randomised study. Psychiatr Res 2018;266:116–23. [DOI] [PubMed] [Google Scholar]
  • [14].Davis LW, Schmid AA, Daggy JK, Yang Z, O'Connor CE, Schalk N, Do A-NL, Maric D, Lazarick D, Knock H. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma Theor Res Pract Pol 2020;12:904–12. [DOI] [PubMed] [Google Scholar]
  • [15].Dindo L, Johnson AL, Lang B, Rodrigues M, Martin L, Jorge R. Development and evaluation of an 1-day acceptance and commitment therapy workshop for veterans with comorbid chronic pain, TBI, and psychological distress: outcomes from a pilot study. Contemp Clin Trials 2020;90:105954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Dueñas M, Salazar A, Ojeda B, Fernández-Palacín F, Micó JA, Torres LM, Failde I. A nationwide study of chronic pain prevalence in the general Spanish population: identifying clinical subgroups through cluster analysis. Pain Med 2015;16:811–22. [DOI] [PubMed] [Google Scholar]
  • [17].Dunne RLKJ, Kenardy J, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain 2012;28:755–65. [DOI] [PubMed] [Google Scholar]
  • [18].Engel CC, Cordova EH, Benedek DM, Liu X, Gore KL, Goertz C, Freed MC, Crawford C, Jonas WB, Ursano RJ. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care 2014;52(suppl 5):S57–64. [DOI] [PubMed] [Google Scholar]
  • [19].Engel CC, Jaycox LH, Freed MC, Bray RM, Brambilla D, Zatzick D, Litz B, Tanielian T, Novak LA, Lane ME, Belsher BE, Olmsted KLR, Evatt DP, Vandermaas-Peeler R, Unützer J, Katon WJ. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Int Med 2016;176:948–56. [DOI] [PubMed] [Google Scholar]
  • [20].Finch J, Ford C, Grainger L, Meiser-Stedman R. A systematic review of the clinician related barriers and facilitators to the use of evidence-informed interventions for post traumatic stress. J Affect Disord 2020;263:175–86. [DOI] [PubMed] [Google Scholar]
  • [21].Fitzcharles M-A, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 2021;397:2098–110. [DOI] [PubMed] [Google Scholar]
  • [22].Garland EL, Nakamura Y, Bryan CJ, Hanley AW, Parisi A, Froeliger B, Marchand WR, Donaldson GW. Mindfulness-oriented recovery enhancement for veterans and military personnel on long-term opioid therapy for chronic pain: a randomized clinical trial. Am J Psychiatr 2024;181:125–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Gasslander N, Andersson G, Bostrom F, Brandelius L, Pelling L, Hamrin L, Gordh T, Buhrman M. Tailored internet-based cognitive behavioral therapy for individuals with chronic pain and comorbid psychological distress: a randomized controlled trial. Cogn Behav Ther 2022;51:408–34. [DOI] [PubMed] [Google Scholar]
  • [24].Geronilla L, Minewiser L, Mollon P, McWilliams M, Clond M. EFT (emotional freedom techniques) remediates PTSD and psychological symptoms in veterans: a randomized controlled replication trial. Energ Psychol J 2016;8:29–41. [Google Scholar]
  • [25].Gjerstad SF, Nordin L, Poulsen S, Spadaro EFA, Palic S. How is trauma-focused therapy experienced by adults with PTSD? A systematic review of qualitative studies. BMC Psychol 2024;12:135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Goldstein E, McDonnell C, Atchley R, Dorado K, Bedford C, Brown RL, Zgierska AE. The impact of psychological interventions on posttraumatic stress disorder and pain symptoms: a systematic review and meta-analysis. Clin J Pain 2019;35:703–12. [DOI] [PubMed] [Google Scholar]
  • [27].Groessl EJ, Hafey C, McCarthy A, Hernandez RM, Prado-Nava M, Casteel D, McKinnon S, Chang DG, Ayers CR, Rutledge TR, Lang AJ, Bormann JE. Yoga plus mantram repetition to reduce chronic pain in veterans with post-traumatic stress disorder: a feasibility trial. Glob Adv Integr Med Health 2023;12:27536130231220623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Harris P, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN. The REDCap consortium: building an international community of software partners. J Biomed Inform 2019;95:103208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch. Cochrane handbook for systematic reviews of interventions version 6.4. Cochrane; www.cochrane.org/handbook. (2023, 23/06/2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31].Kearney DJ, Simpson TL, Malte CA, Felleman B, Martinez ME, Hunt SC. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with gulf war illness. Am J Med 2016;129:204–14. [DOI] [PubMed] [Google Scholar]
  • [32].Kent M, Mardian AS, Regalado-Hustead ML, Gress-Smith JL, Ciciolla L, Kim JL, Scott BA. Adaptive homeostatic strategies of resilient intrinsic self-regulation in extremes (RISE): a randomized controlled trial of a novel behavioral treatment for chronic pain. Front Psychol 2021;12:613341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Lee H, Lamb SE, Bagg MK, Toomey E, Cashin AG, Moseley GL. Reproducible and replicable pain research: a critical review. PAIN 2018;159:1683–9. [DOI] [PubMed] [Google Scholar]
  • [34].Liedl A, Knaevelsrud C. Chronic pain and PTSD: the perpetual avoidance model and its treatment implications. Torture 2008;18:69–76. [PubMed] [Google Scholar]
  • [35].Lumley MA, Yamin JB, Pester BD, Krohner S, Urbanik CP. Trauma matters: psychological interventions for comorbid psychosocial trauma and chronic pain. PAIN 2022;163:599–603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Lykkegaard Ravn S, Andersen TE. Exploring the relationship between posttraumatic stress and chronic pain. Psychiatr Times 2020;37:19–21. [Google Scholar]
  • [37].McKernan LC, McGonigle T, Vandekar SN, Crofford LJ, Williams DA, Clauw DJ, Bruehl S, Corbett BA, Dmochowski RR, Walsh EG, Kelly AG, Sutherland SL, Connors EL, Ryden A, Reynolds WS. A randomized-controlled pilot trial of telemedicine-delivered cognitive-behavioral therapy tailored for interstitial cystitis/bladder pain syndrome. PAIN 2024;165:1748–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].National Institute for Health and Care Excellence. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. National Institute for Health and Care Excellence, 2021. [PubMed] [Google Scholar]
  • [39].Neuner F, Kurreck S, Ruf M, Odenwald M, Elbert T, Schauer M. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther 2010;39:81–91. [DOI] [PubMed] [Google Scholar]
  • [40].Nicholas M, Vlaeyen JW, Rief W, Barke A, Aziz Q, Benoliel R, Cohen M, Evers S, Giamberardino MA, Goebel A, Korwisi B, Perrot S, Svensson P, Wang SJ, Treede RD. The IASP classification of chronic pain for ICD-11: chronic primary pain. PAIN 2019;160:28–37. [DOI] [PubMed] [Google Scholar]
  • [41].Nijs J, Kosek E, Chiarotto A, Cook C, Danneels LA, Fernández-de-Las-Peñas C, Hodges PW, Koes B, Louw A, Ostelo R, Scholten-Peeters GGM, Sterling M, Alkassabi O, Alsobayel H, Beales D, Bilika P, Clark JR, De Baets L, Demoulin C, de Zoete RMJ, Elma Ö, Gutke A, Hanafi R, Hotz Boendermaker S, Huysmans E, Kapreli E, Lundberg M, Malfliet A, Meziat Filho N, Reis FJJ, Voogt L, Zimney K, Smeets R, Morlion B, de Vlam K, George SZ. Nociceptive, neuropathic, or nociplastic low back pain? The low back pain phenotyping (BACPAP) consortium's international and multidisciplinary consensus recommendations. Lancet Rheumatol 2024;6:e178–88. [DOI] [PubMed] [Google Scholar]
  • [42].Nordbrandt MS, Sonne C, Mortensen EL, Carlsson J. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual—a pragmatic randomised controlled trial. PLoS One 2020;15:e0230300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [43].Oliveira CB, Maher CG, Pinto RZ, Traeger AC, Lin C-WC, Chenot J-F, Van Tulder M, Koes BW. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J 2018;27:2791–803. [DOI] [PubMed] [Google Scholar]
  • [44].O'Neil ME, Harik JM, McDonagh MS, Cheney TP, Hsu FC, Cameron DC, Carlson KF, Norman SB, Hamblen JL. Development of the PTSD-Repository: a publicly available repository of randomized controlled trials for posttraumatic stress disorder. J Traumatic Stress 2020;33:410–9. [DOI] [PubMed] [Google Scholar]
  • [45].Peacock KS, Stoerkel E, Libretto S, Zhang W, Inman A, Schlicher M, Cowsar JD, Jr, Eddie D, Walter J. A randomized trial comparing the tennant biomodulator to transcutaneous electrical nerve stimulation and traditional Chinese acupuncture for the treatment of chronic pain in military service members. Mil Med Res 2019;6:37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [46].Pedler A, Sterling M. Patients with chronic whiplash can be subgrouped on the basis of symptoms of sensory hypersensitivity and posttraumatic stress. PAIN 2013;154:1640–8. [DOI] [PubMed] [Google Scholar]
  • [47].Phelps AJ, Lethbridge R, Brennan S, Bryant RA, Burns P, Cooper JA, Forbes D, Gardiner J, Gee G, Jones K, Kenardy J, Kulkarni J, McDermott B, McFarlane AC, Newman L, Varker T, Worth C, Silove D. Australian guidelines for the prevention and treatment of posttraumatic stress disorder: updates in the third edition. Aust N Z J Psychiatr 2022;56:230–47. [DOI] [PubMed] [Google Scholar]
  • [48].R Core Team . R: a language and environment for statistical computing. Vienna, Austria.: R Foundation for Statistical Computing; https://www.r-project.org/. (2021). [Google Scholar]
  • [49].Rabey M, Slater H, O'Sullivan P, Beales D, Smith A. Somatosensory nociceptive characteristics differentiate subgroups in people with chronic low back pain: a cluster analysis. PAIN 2015;156:1874–84. [DOI] [PubMed] [Google Scholar]
  • [50].Reed DE, Fischer IC, Williams RM, Na PJ, Engel CC, Pietrzak RH. Physical health correlates of co-occurring chronic pain and PTSD among U.S. veterans: results from a nationally representative study. Psychiatry Res 2025;348:116440. [DOI] [PubMed] [Google Scholar]
  • [51].Reed DE, Fischer IC, Williams RM, Na PJ, Pietrzak RH. Co-occurring chronic pain and PTSD among US military veterans: prevalence, correlates, and functioning. J Gen Int Med 2024;39:2009–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Reed DE, II, Cobos B, Nabity P, Doolin J, McGeary DD. Comorbid chronic pain and posttraumatic stress disorder: current knowledge, treatments, and future directions. Pain Care Essentials Innov. 2021;211–27. 10.1016/B978-0-323-72216-2.00015-6. [DOI] [Google Scholar]
  • [53].Reed DE, Williams RM, Engel CC, Zeliadt SB. Introducing the integrated model of co-occurring chronic pain and posttraumatic stress disorder: adding meaning-making and existential concepts to current theory. Psychol Trauma Theor Res Pract Pol 2025;17:563–75. [DOI] [PubMed] [Google Scholar]
  • [54].Rijsdijk M, Smits HM, Azizoglu HR, Brugman S, van de Burgt Y, van Charldorp TC, van Gelder DJ, de Grauw JC, van Lange EA, Meye FJ, Strick M, Walravens HW, Winkens LH, Huygen FJ, Drylewicz J, Willemen HL. Identifying patient subgroups in the heterogeneous chronic pain population using cluster analysis. J Pain 2025;28:104792. [DOI] [PubMed] [Google Scholar]
  • [55].Roseen EJ, Pinheiro A, Lemaster CM, Plumb D, Wang S, Elwy AR, Streeter CC, Lynch S, Groessl E, Sherman KJ, Weinberg J, Saper RB. Yoga versus education for veterans with chronic low back pain: a randomized controlled trial. J Gen Int Med 2023;38:2113–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Schneider S, Junghaenel DU, Broderick JE, Ono M, May M, Stone AA. II. Indices of pain intensity derived from ecological momentary assessments and their relationships with patient functioning: an individual patient data meta-analysis. J Pain 2021;22:371–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [57].Sharp TJ, Harvey AG. Chronic pain and posttraumatic stress disorder: mutual maintenance? Clin Psychol Rev 2001;21:857–77. [DOI] [PubMed] [Google Scholar]
  • [58].Shipherd JC, Keyes M, Jovanovic T, Ready DJ, Baltzell D, Worley V, Gordon-Brown V, Hayslett C, Duncan E. Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? J Rehabil Res Develop 2007;44:153–66. [DOI] [PubMed] [Google Scholar]
  • [59].Siqveland J, Hussain A, Lindstrøm JC, Ruud T, Hauff E. Prevalence of posttraumatic stress disorder in persons with chronic pain: a meta-analysis. Front Psychiatr 2017;8:164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Söderlund A, Denison E. Classification of patients with whiplash associated disorders (WAD): reliable and valid subgroups based on the Multidimensional Pain Inventory (MPI-S). Eur J Pain 2006;10:113–9. [DOI] [PubMed] [Google Scholar]
  • [61].Sterling M, Vicenzino B, Souvlis T, Connelly LB. Dry-needling and exercise for chronic whiplash-associated disorders: a randomized single-blind placebo-controlled trial. PAIN 2015;156:635–43. [DOI] [PubMed] [Google Scholar]
  • [62].Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. [DOI] [PubMed] [Google Scholar]
  • [63].Stilling J, Paxman E, Mercier L, Gan LS, Wang M, Amoozegar F, Dukelow SP, Monchi O, Debert C. Treatment of persistent post-traumatic headache and post-concussion symptoms using repetitive transcranial magnetic stimulation: a pilot, double-blind, randomized controlled trial. J Neurotrauma 2020;37:312–23. [DOI] [PubMed] [Google Scholar]
  • [64].Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010;36:1–48. [Google Scholar]
  • [65].Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. PAIN 2000;85:317–32. [DOI] [PubMed] [Google Scholar]
  • [66].Wang SJ, Bytyci A, Izeti S, Kallaba M, Rushiti F, Montgomery E, Modvig J. A novel bio-psycho-social approach for rehabilitation of traumatized victims of torture and war in the post-conflict context: a pilot randomized controlled trial in Kosovo. Conflict Health 2016;10:34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Wicksell RK, Ahlqvist J, Bring A, Melin L, Olsson GL. Can exposure and acceptance strategies improve functioning and life satisfaction in people with chronic pain and whiplash-associated disorders (WAD)? A randomized controlled trial. Cogn Behav Ther 2008;37:169–82. [DOI] [PubMed] [Google Scholar]
  • [68].Williams RM, Day MA, Ehde DM, Turner AP, Ciol MA, Gertz KJ, Patterson D, Hakimian S, Suri P, Jensen MP. Effects of hypnosis vs mindfulness meditation vs education on chronic pain intensity and secondary outcomes in veterans: a randomized clinical trial. PAIN 2022;163:1905–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [69].Yarns BC, Jackson NJ, Alas A, Melrose RJ, Lumley MA, Sultzer DL. Emotional awareness and expression therapy vs cognitive behavioral therapy for chronic pain in older veterans: a randomized clinical trial. JAMA Netw Open 2024;7:e2415842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [70].Zat Ciftci Z, Delibas DH, Kaya T, Kulcu DG, Sari A, Nazlikul H, Coskun Topsakal I, Aydin YE, Kavakci O, Savran C, Konuk E. A randomized controlled trial of eye movement desensitization and reprocessing (EMDR) therapy in the treatment of fibromyalgia. Front Psychiatry Front Res Found 2024;15:1286118. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental digital content associated with this article can be found online at http://links.lww.com/PAIN/C429.

SUPPLEMENTARY MATERIAL
jop-167-756-s001.pdf (617.7KB, pdf)

Articles from Pain are provided here courtesy of Wolters Kluwer Health

RESOURCES